• Login
    View Item 
    •   ORKA Home
    • Conditions, Lifestyle Factors & Interventions
    • Lifestyle, Risks & External Factors
    • Neuroscience
    • View Item
    •   ORKA Home
    • Conditions, Lifestyle Factors & Interventions
    • Lifestyle, Risks & External Factors
    • Neuroscience
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Déjà-vu? Neural and behavioural effects of the 5-HT 4 receptor agonist, prucalopride, in a hippocampal-dependent memory task

    Thumbnail
    Date
    2021-10
    Author
    De Cates, Angharad N
    Wright, Lucy C
    Gibson, Daisy
    Cowen, Philip J
    Harmer, Catherine J
    Murphy, Susannah E
    Metadata
    Show full item record
    Citation
    de Cates AN, Wright LC, Martens MAG, Gibson D, Türkmen C, Filippini N, Cowen PJ, Harmer CJ, Murphy SE. Déjà-vu? Neural and behavioural effects of the 5-HT4 receptor agonist, prucalopride, in a hippocampal-dependent memory task. Transl Psychiatry. 2021 Oct 4;11(1):497
    Abstract
    Cognitive deficits commonly accompany psychiatric disorders but are often underrecognised, and difficult to treat. The 5-HT4 receptor is a promising potential treatment target for cognitive impairment because in animal studies 5-HT4 receptor agonists enhance hippocampal-dependent memory processes. To date, there has been little work translating these effects to humans. We tested whether short-term administration of the 5-HT4 partial agonist, prucalopride, modified behavioural and neural (fMRI) memory processing in 44 healthy human volunteers using an experimental medicine model. We found that participants who had received six days of prucalopride treatment were significantly better at recalling previously seen neutral images and distinguishing them from new images. At a neural level, prucalopride bilaterally increased hippocampal activity and activity in the right angular gyrus compared with placebo. Taken together, these findings demonstrate the potential of 5-HT4-receptor activation for cognitive enhancement in humans, and support the potential of this receptor as a treatment target for cognitive impairment.
    Description
    Open Access
    URI
    https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/1138
    Collections
    • Neuroscience [36]

    Oxford Health copyright © 2019
    Contact Us | Send Feedback | JSPUI
    Powered by KnowledgeArc
     

     

    Browse

    All of ORKACommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsContributor DisciplineThis CollectionBy Issue DateAuthorsTitlesSubjectsContributor Discipline

    My Account

    Login

    Researcher Profiles

    Researchers

    Oxford Health copyright © 2019
    Contact Us | Send Feedback | JSPUI
    Powered by KnowledgeArc